Amedisys, Inc. (AMED) Misses Q4 EPS by 4c; Guides FY12
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amedisys, Inc. (NASDAQ: AMED) reported Q4 EPS of $0.25, $0.04 worse than the analyst estimate of $0.29. Revenue for the quarter came in at $370.7 million versus the consensus estimate of $372.07 million.
Amedisys, Inc. sees FY2012 EPS of $0.95-$1.10, versus the consensus of $0.94. Amedisys, Inc. sees FY2012 revenue of $1.475-$1.525 billion, versus the consensus of $1.45 billion.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
Amedisys, Inc. sees FY2012 EPS of $0.95-$1.10, versus the consensus of $0.94. Amedisys, Inc. sees FY2012 revenue of $1.475-$1.525 billion, versus the consensus of $1.45 billion.
For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
